Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Mesothelioma

fluorodeoxyglucose f18 has been researched along with Mesothelioma in 142 studies

Research

Studies (142)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (2.82)	18.2507
2000's	45 (31.69)	29.6817
2010's	78 (54.93)	24.3611
2020's	15 (10.56)	2.80

Authors

Authors	Studies
Fendler, WP; Ferdinandus, J; Hautzel, H; Herrmann, K; Maier, S; Metzenmacher, M; Plönes, T; Sandach, P; Seifert, R	1
Kandathil, A; Subramaniam, RM	1
Castello, A; Lopci, E; Mansi, L	1
Agackiran, Y; Aloglu, M; Atikcan, S; Cimen, F; Düzgün, S; Senturk, A	1
Inoue, F; Kamikawa, Y; Mori, M; Nishikawa, T; Okabayashi, T; Takahashi, M	1
Ahuja, J; Carter, BW; Gladish, GW; Marom, EM; Shroff, GS; Strange, CD; Truong, MT	1
Aigner, RM; Brcic, L; Fuchsjäger, M; Pernthaler, B; Talakic, E	1
Hou, G; Jin, Y; Peng, P; Zheng, R	1
Alloisio, M; Bottoni, E; Castello, A; Ceresoli, GL; Crepaldi, A; Ferraroli, GM; Lopci, E; Novellis, P; Perrino, M; Rahal, D; Testori, A; Veronesi, G; Voulaz, E; Zucali, PA	1
Chen, Y; Huang, Z; Sun, R	1
Hashimoto, J; Ichikawa, T; Ikoma, H; Kodama, E; Kodama, T	1
Bejuy, O; Colin, DJ; Germain, S; Serre-Beinier, V; Triponez, F	1
Acevedo Báñez, I; Fernández-Rodríguez, P; Jiménez-Hoyuela García, JM; Martín-Marcuartu, JJ; Masero Carretero, JM	1
Wang, W; Xie, P; Yang, J	1
Boldorini, R; Filice, A; Lococo, F; Paci, M; Rapicetta, C; Rena, O; Torricelli, F; Versari, A	1
Ahn, MJ; Choi, JY; Han, J; Im, Y; Jeong, BH; Jhun, BW; Kim, H; Kim, J; Kwon, OJ; Lee, K; Lim, JH; Park, HY; Um, SW; Yoo, H	1
Kobayashi Shimizu, S; Koyama, K; Nishida, N; Okamura, T; Seura, H	1
Cao, J; Chen, Y; Hu, J; Xu, T; Zhang, X	1
Doi, H; Fujimoto, E; Kanemura, S; Kijima, T; Kitajima, K; Kuribayashi, K; Mikami, K; Nakano, T; Negi, Y	1
Bombardieri, E; Bonifacio, C; Bonomi, M; Ceresoli, GL; Chiti, A; Ciocia, G; De Vincenzo, F; Gianoncelli, L; Giordano, L; Lopci, E; Lorenzi, E; Perrino, M; Santoro, A; Setti, LR; Simonelli, M; Zucali, PA	1
Akamine, T; Haratake, N; Kozuma, Y; Maehara, Y; Matsubara, T; Nabeshima, K; Okamoto, T; Shoji, F; Takamori, S; Toyokawa, G; Yamada, Y	1
Braybrooke, JP; Darby, M; Hall, DO; Harvey, JE; Hooper, CE; Lyburn, ID; Masani, V; Maskell, NA; Searle, J; White, P	1
Bradbury, P; Cho, J; de Perrot, M; Elliott, HS; Hussey, D; Metser, U; Noam, T; Veit-Haibach, P	1
Betancourt, SL; Carter, BW; Lichtenberger, JP; Shroff, GS	1
Broggi, S; Calandrino, R; Cattaneo, M; Cuzzocrea, M; Dell'Oca, I; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Mapelli, P; Pasetti, M; Picchio, M; Samanes Gajate, AM	1
Aluja Jaramillo, F; Bhalla, S; Gutierrez, F	1
Broggi, S; Calandrino, R; Cattaneo, MG; Dell'Oca, I; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Pasetti, M; Passoni, P; Picchio, M; Samanes Gajate, AM	1
Balink, H; Edel, JP	1
Arrieta, O; Izquierdo-Sánchez, V; Medina, LA; Muñiz-Hernández, S; Pacheco-Yepez, J; Romero-Piña, ME; Vázquez-Becerra, H	1
Aoyagi, K; Kishida, Y; Koyama, H; Ohno, Y; Seki, S; Yoshikawa, T; Yui, M	1
Ishii, S; Ishii, Y; Kaburagi, T; Nakano, T	1
Cheng, D; Shi, H; Xiao, J; Xiu, Y; Yin, H	1
Abikhzer, G; Arkovitz, M; Gourevich, K; Keidar, Z; Postovsky, S	1
Dong, A; Dong, H; Zuo, C	1
Castellucci, P; Ferretti, A; Fuccio, C; Marzola, MC; Rubello, D; Spinapolice, EG; Trifirò, G	1
Brocken, P; de Geus-Oei, LF; Dekhuijzen, PN; Peters-Bax, L; van der Heijden, HF	1
Fujikawa, A; Kosuda, S; Kyoto, Y; Nakamori, T; Nakamori, Y; Naoi, Y	1
Abakay, A; Abakay, O; Ekici, F; Komek, H; Palanci, Y; Tanrikulu, AC; Tekbas, G	1
Kruse, M; Mercier, G; Paidpally, V; Sherry, SJ; Subramaniam, RM	1
Bille, A; Chicklore, S; Cook, GJ; Landau, D; Lang-Lazdunski, L; Okiror, L; Spicer, J	1
Barrington, SF; Chicklore, S; Cook, GJ; Goh, V; Klabatsa, A; Lang-Lazdunski, L	1
Endo, M; Kaira, K; Kenmotsu, H; Murakami, H; Naito, T; Nakajima, T; Ohde, Y; Ono, A; Takahashi, T; Yamamoto, N	1
Fukui, T; Ishiguro, F; Kawaguchi, K; Nakamura, S; Taniguchi, T; Usami, N; Yokoi, K	1
Fujita, S; Imai, Y; Katakami, N; Takeshita, J	1
Bærentzen, S; Madsen, GA; Rasmussen, TR	1
Domènech-Vilardell, A; Ichise, M; Rasiej, MJ; Taub, RN	1
Le, BB; Nguyen, BD	1
Ceresoli, GL; Chiti, A; Gemelli, M; Gianoncelli, L; Giordano, L; Lopci, E; Lorenzi, E; Perrino, M; Santoro, A; Zucali, PA	1
Astoul, P; Dutau, H; Laroumagne, S; Loundou, A; Lucchini, S; Maldonado, F; Pinelli, V; Roca, E	1
Torigian, DA; Vilstrup, MH	1
Berg, AS; Brustugun, OT; Løndalen, A	1
Francis, RJ; Lee, YC; Millward, MJ; Morandeau, L; Nowak, AK; Segal, A; Segard, T	1
Doi, H; Kitajima, K; Kuribayashi, K	1
Akin, O; Arslan, A; Deniz, E; Ozcakir-Tomruk, C	1
Ak Sivrikoz, İ; Çavuşoğlu, Y; Dernek, S; Kasapoğlu Dündar, E; Önner, H	1
Lu, P; Ma, J; Sun, Y; Yu, H	1
Chillura, I; Migliore, M; Milazzotto, R; Militello, C; Pagana, A; Pergolizzi, S; Privitera, G; Raffaele, L; Salamone, V; Spatola, C; Tocco, A	1
Botticella, A; Coolen, J; De Ruysscher, D; Defraene, G; Deroose, CM; Nackaerts, K; Nafteux, P; Peeters, S; Ricardi, U	1
Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A	1
Doi, H; Fukushima, K; Hasegawa, S; Hashimoto, M; Hirota, S; Kitajima, K; Kuribayashi, K; Nakano, T; Tanooka, M; Tsuchitani, T	1
Doi, H; Funaguchi, N; Hasegawa, S; Kanemura, S; Kitajima, K; Kuribayashi, K; Mikami, K; Nakano, T; Shibata, E	1
Bakrin, N; Dubreuil, J; Giammarile, F; Glehen, O; Isaac, S; Passot, G; Rousset, P; Rubello, D; Skanjeti, A	1
Mahmood, S; Martinez de Llano, SR	1
Berthelsen, AK; Brenøe, J; Loft, A; Ravn, J; Sørensen, JB	1
Hirata, K; Kawabe, J; Kimura, T; Koyama, K; Kudoh, S; Mitsuoka, S; Shiomi, S; Yoshimura, N	1
Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K; Yamashita, K	1
Ishikawa, S; Kameyama, R; Kimura, N; Nishiyama, Y; Togami, T; Yamamoto, Y	1
Schaefer, NG; Seifert, B; Soyka, JD; Stahel, RA; Steinert, HC; Veit-Haibach, P	1
Aubry, MC; Jett, J; Peller, PJ; Subramaniam, RM; Wilcox, B	1
Aubry, MC; Aughenbaugh, GL; Jett, JR; Nichols Iii, FC; Peller, PJ; Subramaniam, RM; Wilcox, BE	1
Akin, O; Ciftci, H; Falay, O; Kutlu, CA; Orki, A; Tasci, AE; Urek, S	1
Chamberlain, MC; Eaton, KD; Fink, JR; Tredway, T	1
Dolek, Y; Nursal, GN; Onal, C; Pehlivan, B; Topkan, E; Yavuz, AA; Yavuz, MN; Yuksel, O	1
Gerbaudo, VH; Gill, RR; Hatabu, H; Sugarbaker, DJ	1
Chen, LK; Chen, SW; Chen, YK; Yeh, CL	1
Ak, G; Ak, I; Dundar, E; Entok, E; Erginel, S; Metintas, M; Yildirim, H	1
Huang, YC; Lee, MY; Tu, DG; Wu, JD	1
Barrington, S; Cane, P; Landau, D; Lang-Lazdunski, L; Pilling, J; Rankin, S; Spicer, J; Tan, C	1
Boucek, J; Byrne, MJ; Francis, RJ; McCoy, MJ; Millward, MJ; Musk, AW; Nowak, AK; Phillips, MJ; Robins, P; Segal, A; van der Schaaf, AA	1
Ahn, MJ; Chung, MJ; Hyun, SH; Kim, BT; Kim, J; Kim, TS; Lee, HY; Lee, KS; Shim, YM; Yi, CA	1
Dartnell, JA; Lang-Lazdunski, L; Pilling, J	1
Gallazzi, MS; Gotti, G; Granato, F; Luzzi, L; Paladini, P; Tenconi, S; Voltolini, L	1
Aizawa, H; Azuma, K; Fujimoto, K; Hayabuchi, N; Hirose, Y; Ishibashi, M; Kaida, H; Kobayashi, M; Kurata, S; Takamori, S	1
Routledge, T; Scarci, M; Sharif, S; Zahid, I	2
Brader, P; Daghighian, F; Fong, Y; Gönen, M; González, L; González, SJ; Strong, VE; Wong, J; Zakowski, M	1
Schaefer, NG; Soyka, JD; Stahel, RA; Steinert, HC; Veit-Haibach, P	1
Alavi, A; Basu, S; Saboury, B; Torigian, DA	1
Gerbaudo, VH; Hatabu, H; Mamede, M; Sugarbaker, DJ; Trotman-Dickenson, B	1
Broaddus, VC; Feng, J; Gao, D; He, J; Iyer, AK; Lan, X; Liu, B; Seo, Y; Su, Y; Vanbrocklin, HF; Zhang, X; Zhu, X	1
Brader, P; Fong, Y; Gönen, M; González, L; González, SJ; Strong, VE; Wong, J; Zakowski, M	1
Cafarotti, S; Granone, P; Margaritora, S; Porziella, V	1
Churcher, K; Feigen, M; Hamilton, C; Lawford, C; Lee, ST; Scott, AM; Zupan, E	1
Abe, Y; Goya, T; Ishida, J; Kanazawa, M; Machida, K; Ozeki, Y; Sakai, H; Sakata, I; Tamura, A; Tamura, K; Uematsu, K	1
Broggi, S; Calandrino, R; Cattaneo, GM; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Fodor, A; Gianolli, L; Pasetti, M	1
Endo, M; Hanaoka, H; Kaira, K; Koh, Y; Kondo, H; Nakajima, T; Oriuchi, N; Serizawa, M; Takahashi, T; Yamamoto, N	1
Bersanelli, M; Dubini, A; Genestreti, G; Matteucci, F; Moretti, A; Piciucchi, S; Sanna, S; Scarlattei, M; Scarpi, E; Tiseo, M	1
Ciarallo, A; Lisbona, R; Makis, W; Novales-Diaz, JA	1
Alexander, HR; Cao, Q; Chen, W; Dilsizian, V; Hausner, PF; Heath, J; Lu, M	1
Aga, F; Nishiyama, Y; Norikane, T; Yamamoto, Y	1
Fukuoka, K; Hasegawa, S; Miyata, Y; Nakano, T; Okada, M; Takuwa, T; Tsutani, Y	1
Baresic, T; Bearz, A; Dassie, A; Del Conte, A; Drigo, A; Franchin, G; Gobitti, C; Minatel, E; Pagan, V; Polesel, J; Rumeileh, IA; Trovo, M; Trovo, MG	1
Astoul, P; Berdah, S; Dutau, H; Laroumagne, S; Maldonado, F; Roca, E; Vandemoortele, T	1
Alavi, A; Kwee, TC; Torigian, DA	1
Hamada, N; Kume, M; Naruse, K; Ogushi, F; Shinohara, T; Shiota, N	1
Avril, N; Baccarini, M; Luong, P; Phillips, MM; Sheaff, MT; Stephen, E; Szlosarek, PW; Szyszko, T	1
Britz-Cunningham, S; Di Carli, MF; Gerbaudo, VH; Mauceri, C; Sugarbaker, DJ; Treves, ST	1
Constable, CJ; Eade, TN; Fulham, MJ	1
Gerbaudo, VH	1
Akhurst, T; Flores, RM; Gonen, M; Larson, SM; Rusch, VW	1
Boan, JF; Castellano, JM; Cortes, J; Garcia-Velloso, MJ; Rodriguez, J; Rodriguez-Espiteri, N; Torre, W	1
Britz-Cunningham, S; Gerbaudo, VH; Sugarbaker, DJ; Treves, ST	1
Aide, N; Balogova, S; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N	1
Boschi, S; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Marengo, M; Martoni, A; Monetti, N; Moretti, A; Nanni, C; Pettinato, C; Pinto, C	1
Haberkorn, U	1
Bertin, F; Bonnaud, F; Ducloux, T; Gaillard, S; Maubon, A; Melloni, B; Monteil, J; Vandroux, JC; Verbeke, S; Vincent, F	1
Greenspan, B; Singh, A; Thomas, A	1
Flores, RM	1
Gotoh, Y; Higashi, T; Ishibashi, K; Kawasaki, A; Morita, H; Yamaguchi, Y; Yamasaki, M	1
Steinert, HC	1
Banayan, S; Billotey, C; Hot, A; Janier, M; Ninet, J; Zurlinden, O	1
Meignan, M; Paone, G	1
Alloisio, M; Ceresoli, GL; Chiti, A; Incarbone, M; Lutman, RF; Rodari, M; Salamina, S; Santoro, A; Zucali, PA	1
Quint, LE	1
Duvvi, H; Ohata, N; Ohki, M; Omura, Y; Shimotsuura, Y	1
Albelda, SM; Benedict, W; Brown, JL; Carroll, RG; Corbley, MJ; Gillespie, CT; Haas, A; Heitjan, DF; Ho, M; Hodinka, R; June, CH; Kaiser, LR; Kanther, M; Kapoor, V; Litzky, LA; Lord, EM; Machuzak, M; Parr, M; Pastan, I; Recio, A; Sterman, DH; Sun, J; Vachani, A; Vonderheide, RH; Zhang, XQ	1
Boucek, JA; Byrne, MJ; Francis, RJ; Millward, MJ; Musk, AW; Nowak, AK; Patrikeos, AP; Phillips, M; Price, R; van der Schaaf, AA	1
Ceresoli, GL; Chiti, A; Santoro, A	1
Armato, SG; Ceresoli, GL; Entwisle, J; Kindler, HL; Misri, R; Nowak, AK; Truong, MT; Zhao, B	1
Buck, AK; Hombach, V; Krüger, S; Mottaghy, FM; Pauls, S; Reske, SN; Schelzig, H	1
Boterberg, T; Goethals, I; Ost, P; Rottey, S; Smeets, P; Stragier, B	1
Benson, MJ; Carden, CP; Larkin, JM; Montes, A; Myerson, JS; O'Brien, ME; Popat, S	1
Delbeke, D; Knight, SB; Sandler, MP; Stewart, JR	1
Alavi, A; Albelda, SM; Bénard, F; Kaiser, LR; Smith, RJ; Sterman, D	2
Buchmann, I; Buck, A; Elsner, K; Gfrörer, W; Guhlmann, CA; Kotzerke, J; Reske, SN; Schirrmeister, H	1
Caputo, G; Challa, S; Clary-Macy, C; Hawkins, R; Jablons, D; Merrick, SH; Sasse, KC; Schneider, DB	1
Belhocine, TZ; Bury, T; Daenen, F; Duysinx, B; Rigo, P	1
Dussek, J; Hain, SF; Ng, DC; O'Doherty, MJ	1
Akaizawa, T; Fukuda, H; Itoh, M; Kubota, K; Ono, S; Ozaki, K; Tashiro, M; Yamada, K; Yamaguchi, K	1
Adam, LE; Alavi, A; Cortés-Blanco, A; Lee, JH; Loman, JC; Martínez-Lázaro, R; Pourdehnad, M; Rossman, MD; Yamamoto, AJ; Zhuang, HM	1
Garg, K; Lynch, DA	1

Reviews

20 review(s) available for fluorodeoxyglucose f18 and Mesothelioma

Article	Year
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma. Seminars in nuclear medicine, 2022, Volume: 52, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma. Seminars in nuclear medicine, 2022, Volume: 52, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2022
FDG PET/CT for Staging and Restaging Malignant Mesothelioma. Seminars in nuclear medicine, 2022, Volume: 52, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography	2022
MR Imaging of Pleural Neoplasms. Topics in magnetic resonance imaging : TMRI, 2018, Volume: 27, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2018
Pleural tumours and tumour-like lesions. Clinical radiology, 2018, Volume: 73, Issue:12 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2018
¹⁸F-FDG-PET/CT in malignant mesothelioma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2013, Volume: 67, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
FDG PET/CT in the management of primary pleural tumors and pleural metastases. AJR. American journal of roentgenology, 2013, Volume: 201, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mesothelioma; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden	2013
[18F]Fluorodeoxyglucose PET in Thoracic Malignancies. PET clinics, 2014, Volume: 9, Issue:4 Topics: Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymus Neoplasms	2014
Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma. Japanese journal of radiology, 2016, Volume: 34, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleura; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay. Nuclear medicine communications, 2017, Volume: 38, Issue:1 Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms	2017
18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma. Journal of medical imaging and radiation oncology, 2009, Volume: 53, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Mesothelioma; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Current trends in radiologic management of malignant pleural mesothelioma. Seminars in thoracic and cardiovascular surgery, 2009,Summer, Volume: 21, Issue:2 Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mesothelioma; Neoplasm Invasiveness; Neoplasm Staging; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgical Procedures; Tomography, X-Ray Computed; Treatment Outcome	2009
What is the best way to diagnose and stage malignant pleural mesothelioma? Interactive cardiovascular and thoracic surgery, 2011, Volume: 12, Issue:2 Topics: Diagnostic Imaging; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Mesothelioma; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2011
Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment. Molecular imaging and biology, 2011, Volume: 13, Issue:5 Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Mesothelioma; Multimodal Imaging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2011
Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? Interactive cardiovascular and thoracic surgery, 2011, Volume: 12, Issue:5 Topics: Benchmarking; Biopsy; Diagnosis, Differential; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2011
Oncological applications of positron emission tomography for evaluation of the thorax. Journal of thoracic imaging, 2013, Volume: 28, Issue:1 Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphoma; Mesothelioma; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thorax; Thymus Gland; Thymus Neoplasms	2013
[(18)F]-FDG PET and localized fibrous mesothelioma. Lung, 2003, Volume: 181, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Radiopharmaceuticals; Spain; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Positron emission tomography in the diagnosis of mesothelioma. Lung cancer (Amsterdam, Netherlands), 2004, Volume: 45 Suppl 1 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mesothelioma; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
PET in lung cancer. Chang Gung medical journal, 2005, Volume: 28, Issue:5 Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2005
[18-Fluoro-deoxy-glucose (15FDG) positon emission tomography (PET) for the evaluation of malignant pleural disease]. Revue de pneumologie clinique, 2006, Volume: 62, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Mesothelioma; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2006

Trials

6 trial(s) available for fluorodeoxyglucose f18 and Mesothelioma

Article	Year
In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma. Nuclear medicine communications, 2019, Volume: 40, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography	2019
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma. Nuclear medicine communications, 2018, Volume: 39, Issue:2 Topics: Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Positron Emission Tomography Computed Tomography; Survival Analysis	2018
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8 Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed	2010
Role of 18F-FDG PET for evaluating malignant pleural mesothelioma. Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:2 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography	2004
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Aug-01, Volume: 13, Issue:15 Pt 1 Topics: Adenoviridae; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Female; Fluorodeoxyglucose F18; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Interferon-beta; Killer Cells, Natural; Male; Mesothelioma; Middle Aged; Pleural Effusion, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; T-Lymphocytes, Cytotoxic	2007
Advantage of delayed whole-body FDG-PET imaging for tumour detection. European journal of nuclear medicine, 2001, Volume: 28, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Mesothelioma; Neoplasms; Radiopharmaceuticals; Sarcoidosis; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting	2001

Other Studies

116 other study(ies) available for fluorodeoxyglucose f18 and Mesothelioma

Article	Year
Factors affecting the life expectancy in malignant pleural mesothelioma: Our 10 years of studies and experience. Medicine, 2022, Sep-30, Volume: 101, Issue:39 Topics: Female; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Pleural Diseases; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2022
[Primary Pericardial Malignant Mesothelioma:Report of a Case]. Kyobu geka. The Japanese journal of thoracic surgery, 2022, Volume: 75, Issue:12 Topics: Aged; Calbindin 2; Claudin-4; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Keratins; Lung Neoplasms; Mediastinal Neoplasms; Mesothelioma; Mesothelioma, Malignant; Thymus Neoplasms	2022
Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma. Advances in anatomic pathology, 2023, Jul-01, Volume: 30, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pericardium; Pleura; Pleural Neoplasms; Positron Emission Tomography Computed Tomography	2023
18F-FDG PET/CT in Primary Mesothelioma of the Liver. Clinical nuclear medicine, 2023, Jan-01, Volume: 48, Issue:1 Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Ovarian Metastasis From Diffuse Epithelioid Malignant Mesothelioma Revealed by 18 F-FDG PET/CT. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Mesothelioma, Malignant; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
18F-FDG PET/CT Findings of Ovarian Mesothelioma: A Case Study. Clinical nuclear medicine, 2019, Volume: 44, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography	2019
18F-FDG Uptake of Localized Malignant Peritoneal Mesothelioma. Clinical nuclear medicine, 2020, Volume: 45, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2020
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice. Journal of visualized experiments : JoVE, 2019, 12-21, Issue:154 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Organ Size; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Xenograft Model Antitumor Assays	2019
99mTc-HDP Bone Scintigraphy, SPECT/CT, and 18F-FDG PET/CT Diagnosis Imaging of Incidental Pleural Mesothelioma in a Patient With Biochemical Recurrences of Prostate Cancer: Is it Really a Coincidence? Clinical nuclear medicine, 2020, Volume: 45, Issue:3 Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Organotechnetium Compounds; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography	2020
Tongue metastasis was the first sign of malignant pleural mesothelioma detected by PET/CT. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tongue	2020
18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results. Interactive cardiovascular and thoracic surgery, 2020, 04-01, Volume: 30, Issue:4 Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results	2020
Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma. PloS one, 2020, Volume: 15, Issue:2 Topics: Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate	2020
A Case of Localized Malignant Peritoneal Mesothelioma With Lung Cancer Detected by 18F-FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:10 Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography	2020
A Case of Localized Malignant Peritoneal Mesothelioma Evaluated by 18F-FDG PET/CT. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis	2020
First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma. Expert review of anticancer therapy, 2017, Volume: 17, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2017
Prognostic and predictive role of [ Cancer medicine, 2017, Volume: 6, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Staging; Pemetrexed; Pleurodesis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome	2017
A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis. Anticancer research, 2017, Volume: 37, Issue:12 Topics: Aged, 80 and over; Biomarkers, Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Suppressor Proteins; Ubiquitin Thiolesterase	2017
The British journal of radiology, 2018, Volume: 91, Issue:1086 Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Tomography, X-Ray Computed	2018
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals	2018
Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs. Clinical lung cancer, 2019, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Dose Hypofractionation; Radiotherapy, Intensity-Modulated; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome	2019
18F-FDG PET/CT Revealing Constrictive Pericarditis as the Only Manifestation of Malignant Mesothelioma. Clinical nuclear medicine, 2019, Volume: 44, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pericarditis, Constrictive; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Biodistribution and Tumor Uptake of Molecules (Basel, Switzerland), 2018, Nov-29, Volume: 23, Issue:12 Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Imaging, Three-Dimensional; Liver; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays	2018
Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging. AJR. American journal of roentgenology, 2019, Volume: 212, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging	2019
Usefulness of new flex-rigid pleuroscopy in the diagnosis of malignant pleural mesothelioma. BMJ case reports, 2019, Jan-14, Volume: 12, Issue:1 Topics: Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracoscopy; Tomography, X-Ray Computed	2019
Focal Peritoneal Mesothelioma Demonstrated on FDG PET/CT. Clinical nuclear medicine, 2019, Volume: 44, Issue:11 Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Neoplasm Grading; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography	2019
Role of 18F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma. Clinical nuclear medicine, 2013, Volume: 38, Issue:8 Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Multimodal Imaging; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT. Clinical nuclear medicine, 2014, Volume: 39, Issue:7 Topics: Cystadenocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer. Respiration; international review of thoracic diseases, 2014, Volume: 87, Issue:1 Topics: Aged; Ambulatory Care; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed	2014
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 cases. Japanese journal of radiology, 2013, Volume: 31, Issue:8 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma. European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:9 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Mesothelioma; Middle Aged; Multivariate Analysis; Pleural Neoplasms; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Socioeconomic Factors; Survival	2013
Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication. Nuclear medicine communications, 2013, Volume: 34, Issue:11 Topics: Aged; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2013
The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms. Oncology reports, 2014, Volume: 31, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Dihydrouracil Dehydrogenase (NADP); Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Microvessels; Middle Aged; Neovascularization, Pathologic; Neuroendocrine Tumors; Orotate Phosphoribosyltransferase; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymidylate Synthase; Thymus Neoplasms; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Young Adult	2014
FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma. General thoracic and cardiovascular surgery, 2014, Volume: 62, Issue:3 Topics: Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Vascular Access Devices	2014
Pleural metastases from papillary thyroid carcinoma mimicking mesothelioma. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:2 Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Diagnosis, Differential; Fatal Outcome; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed	2014
A case of pleural epithelioid sarcoma of proximal type presenting as malignant pleural mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:10 Topics: Biomarkers, Tumor; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed	2013
Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2016, Volume: 60, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Peritoneal Neoplasms; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Young Adult	2016
Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging. Clinical nuclear medicine, 2015, Volume: 40, Issue:1 Topics: Aged; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lower Extremity; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasms, Second Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed	2015
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome	2015
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? Respiration; international review of thoracic diseases, 2015, Volume: 89, Issue:6 Topics: Aged; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Thoracoscopy; Tomography, X-Ray Computed	2015
[Typical growth pattern in malignant pleural mesothelioma]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2015, Jun-16, Volume: 135, Issue:11 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT. Lung cancer (Amsterdam, Netherlands), 2015, Volume: 90, Issue:1 Topics: Aged; Aged, 80 and over; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Misonidazole; Pilot Projects; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
A case report of metastasis of malignant mesothelioma to the retromolar trigone. World journal of surgical oncology, 2016, Jul-20, Volume: 14, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Calbindin 2; Cisplatin; Deoxycytidine; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Mouth Neoplasms; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiography, Panoramic; Radiotherapy, Adjuvant	2016
F-18 FDG PET/CT images of a rare primer cardiac tumour: Primary Pericardial Mesothelioma. Anatolian journal of cardiology, 2016, Volume: 16, Issue:8 Topics: Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Mesothelioma; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion. PloS one, 2016, Volume: 11, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma. Future oncology (London, England), 2016, Volume: 12, Issue:23s Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Treatment Outcome; Tumor Burden	2016
Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study. Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:12 Topics: Aged; Computer Simulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasm Staging; Organ Sparing Treatments; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Tumor Burden	2016
Prognostic value of pretreatment volume-based quantitative European journal of radiology, 2017, Volume: 86 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2017
Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma. European journal of radiology, 2017, Volume: 86 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Treatment Outcome	2017
The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma. Nuclear medicine communications, 2017, Volume: 38, Issue:4 Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mesothelioma; Mesothelioma, Cystic; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Young Adult	2017
Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Clinical nuclear medicine, 2008, Volume: 33, Issue:7 Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Mesothelioma; Neoplasm Metastasis; Neoplasms, Second Primary; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2008, Volume: 34, Issue:5 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Mesothelioma; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures	2008
Monitoring of chemotherapy response in malignant pleural mesothelioma using fluorodeoxyglucose positron emission tomography. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:23 Topics: Antineoplastic Agents; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography	2008
Is FDG-PET/CT useful for managing malignant pleural mesothelioma? The journal of medical investigation : JMI, 2009, Volume: 56, Issue:1-2 Topics: Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Dual time point FDG PET for evaluation of malignant pleural mesothelioma. Nuclear medicine communications, 2009, Volume: 30, Issue:1 Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors	2009
Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung cancer (Amsterdam, Netherlands), 2010, Volume: 67, Issue:3 Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Female; Fluorodeoxyglucose F18; Glutamates; Glycolysis; Guanine; Humans; Male; Mesothelioma; Palliative Care; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Treatment Outcome	2010
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clinical lung cancer, 2009, Volume: 10, Issue:4 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed	2009
The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases. The Thoracic and cardiovascular surgeon, 2009, Volume: 57, Issue:4 Topics: Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Diseases; Pleural Effusion; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Surgery, Video-Assisted; Thoracotomy; Tomography, X-Ray Computed; Tuberculosis, Pleural	2009
Intradural intramedullary spinal cord metastasis due to mesothelioma. Journal of neuro-oncology, 2010, Volume: 97, Issue:1 Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Neurosurgical Procedures; Positron-Emission Tomography; Spinal Cord; Spinal Cord Neoplasms; Thoracotomy; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed	2010
Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma. Radiation oncology (London, England), 2009, Sep-16, Volume: 4 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed	2009
Abnormal FDG PET imaging in tuberculosis appearing like mesothelioma: anatomic delineation by CT can aid in differential diagnosis. Clinical nuclear medicine, 2009, Volume: 34, Issue:11 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis	2009
Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Asbestos; Carcinogens; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pilot Projects; Pleural Diseases; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT. Spine, 2009, Oct-01, Volume: 34, Issue:21 Topics: Fluorodeoxyglucose F18; Humans; Low Back Pain; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, X-Ray Computed	2009
Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:3 Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome	2010
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Annals of surgical oncology, 2010, Volume: 17, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasms, Glandular and Epithelial; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed	2010
Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. The Thoracic and cardiovascular surgeon, 2010, Volume: 58, Issue:4 Topics: Aged; Biopsy; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Mediastinoscopy; Mesothelioma; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pleural Neoplasms; Pleurodesis; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Talc; Tomography, X-Ray Computed; Treatment Outcome	2010
Pleural granuloma mimicking malignancy 42 years after slurry talc injection for primary spontaneous pneumothorax. European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2010, Volume: 44, Issue:3-4 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Male; Mesothelioma; Middle Aged; Pleural Diseases; Pleural Neoplasms; Pleurodesis; Pneumothorax; Radiopharmaceuticals; Talc; Time Factors; Tomography, X-Ray Computed	2010
Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease. Japanese journal of radiology, 2010, Volume: 28, Issue:6 Topics: Aged; Aged, 80 and over; Asbestos; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Mesothelioma; Middle Aged; Osteopontin; Pleura; Pleural Diseases; Pleural Neoplasms; Pleurisy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, Spiral Computed	2010
An analysis of the utility of handheld PET probes for the intraoperative localization of malignant tissue. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2011, Volume: 15, Issue:2 Topics: Animals; Area Under Curve; Beta Particles; Fluorodeoxyglucose F18; Intraoperative Care; Mesothelioma; Neoplasm Transplantation; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Rats; Rats, Nude; ROC Curve	2011
Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT. European journal of radiology, 2012, Volume: 81, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorodeoxyglucose F18; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome	2012
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:5 Topics: Abdomen; Adult; Aged; Aged, 80 and over; Algorithms; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiography, Abdominal; Radiography, Thoracic; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Treatment Failure	2011
Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas. Cancer research, 2011, Apr-01, Volume: 71, Issue:7 Topics: Animals; Fluorodeoxyglucose F18; Humans; Immunotoxins; Isotope Labeling; Male; Mesothelioma; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Single-Chain Antibodies; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	2011
Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes. Surgical endoscopy, 2011, Volume: 25, Issue:10 Topics: Animals; Fluorodeoxyglucose F18; Lymph Nodes; Lymphatic Metastasis; Mesothelioma; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Rats; Rats, Nude; ROC Curve; Sensitivity and Specificity; Transplantation, Heterologous	2011
eComment: What is the best way to diagnose and stage malignant pleural mesothelioma? Interactive cardiovascular and thoracic surgery, 2011, Volume: 12, Issue:5 Topics: Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2011
Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation. Journal of medical imaging and radiation oncology, 2011, Volume: 55, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed	2011
Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma. Oncology reports, 2012, Volume: 27, Issue:2 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed	2012
PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2011, Volume: 187, Issue:11 Topics: Adult; Aged; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Fatty Acids; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Palliative Care; Pilot Projects; Pleural Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Computer-Assisted; Radiotherapy, Image-Guided; Salvage Therapy; Tomography, Spiral Computed; Tomography, X-Ray Computed	2011
Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:8 Topics: Adult; Aged; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; TOR Serine-Threonine Kinases	2012
Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma. Technology in cancer research & treatment, 2012, Volume: 11, Issue:2 Topics: Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed	2012
Sarcomatoid carcinoma (carcinosarcoma) of the lung mimics malignant pleural mesothelioma on 18F-FDG PET/CT: a report of 2 cases. Clinical nuclear medicine, 2012, Volume: 37, Issue:4 Topics: Aged; Carcinosarcoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clinical nuclear medicine, 2012, Volume: 37, Issue:5 Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
A case of primary pericardial mesothelioma detected by 18F-FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:5 Topics: Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Mesothelioma; Middle Aged; Multimodal Imaging; Pericardium; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4 Topics: Aged; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Metabolism; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2013
Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Survival Rate	2012
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough. Lung cancer (Amsterdam, Netherlands), 2013, Volume: 79, Issue:2 Topics: Aged; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Mesothelioma; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracoscopy; Tomography, X-Ray Computed	2013
Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma. BMC infectious diseases, 2013, Jan-14, Volume: 13 Topics: Adult; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Multimodal Imaging; Pleura; Pleural Neoplasms; Positron-Emission Tomography; Thoracoscopy; Tomography, X-Ray Computed; Tuberculosis, Pleural	2013
Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Argininosuccinate Synthase; Asbestos; Cisplatin; Clinical Trials as Topic; DNA Methylation; Fatal Outcome; Fluorodeoxyglucose F18; Glutamates; Guanine; Humans; Hydrolases; Male; Mesothelioma; Middle Aged; Mutation; Occupational Exposure; Pemetrexed; Pleural Effusion, Malignant; Pleural Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Promoter Regions, Genetic; Radiopharmaceuticals	2013
Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:9 Topics: Algorithms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Male; Mediastinal Neoplasms; Mesothelioma; Middle Aged; Pleura; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2002
Primary malignant peritoneal mesothelioma: appearance on F-18 FDG positron emission tomographic images. Clinical nuclear medicine, 2002, Volume: 27, Issue:12 Topics: Aged; Asbestos; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed	2002
18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero... Nuclear medicine communications, 2003, Volume: 24, Issue:6 Topics: Castleman Disease; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2003
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. The Journal of thoracic and cardiovascular surgery, 2003, Volume: 126, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasm Staging; New York; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Statistics as Topic; Thoracic Cavity; Thoracic Surgical Procedures; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2003
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax, 2003, Volume: 58, Issue:12 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Pleural Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2003
[[18F]-FDG imaging in apparently isolated pleural lesions]. Revue de pneumologie clinique, 2003, Volume: 59, Issue:5 Pt 1 Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pleural Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2003
Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. The European respiratory journal, 2004, Volume: 24, Issue:5 Topics: Adult; Aged; Biopsy; False Positive Reactions; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Mesothelioma; Middle Aged; Pleural Diseases; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2004
Positron emission tomography helps in excluding distant lesions in a case of mesothelioma. Clinical nuclear medicine, 2005, Volume: 30, Issue:1 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals	2005
The role of PET in the surgical management of malignant pleural mesothelioma. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 49 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis	2005
[A case of peritoneal malignant mesothelioma that FDG-PET was useful for a supporting diagnosis]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:7 Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals	2005
Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome: detection by 18F-FDG PET. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Paraneoplastic Syndromes; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2006
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-01, Volume: 24, Issue:28 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Female; Fluorodeoxyglucose F18; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Palliative Care; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2006
PET: other thoracic malignancies. Cancer imaging : the official publication of the International Cancer Imaging Society, 2006, Oct-31, Volume: 6 Topics: Carcinoma; Cost-Benefit Analysis; Diagnostic Imaging; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mesothelioma; Neoplasm Staging; Patient Care Planning; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymoma; Thymus Neoplasms	2006
Reduced glucose uptake with markedly increased gastrin releasing peptide, osteopontine & asbestos found in dark black areas of PET Scan of chest wall in patient with mesothelioma. Acupuncture & electro-therapeutics research, 2006, Volume: 31, Issue:3-4 Topics: Aged; Asbestos; Fluorodeoxyglucose F18; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Male; Mesothelioma; Osteopontin; Positron-Emission Tomography; Radiopharmaceuticals; Thorax	2006
Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:9 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate	2007
11C-labeled methionine and evaluation of malignant pleural mesothelioma. The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19 Topics: Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Methionine; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2007
Current state and future directions of pleural mesothelioma imaging. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 59, Issue:3 Topics: Diagnosis, Computer-Assisted; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Mesothelioma; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2008
Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma. Nuklearmedizin. Nuclear medicine, 2007, Volume: 46, Issue:6 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Radiography, Thoracic; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report. Journal of thoracic imaging, 2008, Volume: 23, Issue:1 Topics: Adult; Chest Pain; Diagnosis, Differential; Dyspnea; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Mesothelioma; Pericardium; Positron-Emission Tomography; Pulmonary Edema; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed	2008
Good vibrations and the power of positron thinking: positron emission tomography and endoscopic ultrasound in staging of mesothelioma-two case reports. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:5 Topics: Combined Modality Therapy; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed	2008
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest, 1996, Volume: 109, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neurilemmoma; Pneumonia; Predictive Value of Tests; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Tuberculosis, Pulmonary	1996
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest, 1998, Volume: 114, Issue:3 Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998
Prognostic value of FDG PET imaging in malignant pleural mesothelioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:8 Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed	1999
[F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes]. Nuklearmedizin. Nuclear medicine, 1999, Volume: 38, Issue:8 Topics: Adult; Aged; Carcinoma, Bronchogenic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Pleural Effusion; Pleural Effusion, Malignant; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. The Journal of thoracic and cardiovascular surgery, 2000, Volume: 120, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Pleural Neoplasms; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed	2000
Typical appearance of mesothelioma on an F-18 FDG positron emission tomograph. Clinical nuclear medicine, 2000, Volume: 25, Issue:8 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed	2000
Prognostic value of FDG PET imaging in malignant pleural mesothelioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:8 Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2000
Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nuclear medicine communications, 2001, Volume: 22, Issue:10 Topics: Blood Glucose; Fluorodeoxyglucose F18; Humans; Inflammation; Mesothelioma; Monocytes; Neoplasms; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tumor Cells, Cultured	2001
Imaging of thoracic occupational and environmental malignancies. Journal of thoracic imaging, 2002, Volume: 17, Issue:3 Topics: Aged; Aged, 80 and over; Asbestos; Carcinogens, Environmental; Carcinoma, Bronchogenic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Mortality; Neoplasm Recurrence, Local; Neoplasm Staging; Occupational Diseases; Pulmonary Atelectasis; Radiography; Silicosis; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed	2002